What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Moving Average Envelope



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 31 12.6 0.19% 0.24% 57.4% -3.7% 250.9%
SHORT 31 11.5 0.16% 0.19% 6.3% -4.1% -80.0%


Technical Analysis

Opthea (OPT.AX)



Last Signal:


Trading: HOLD @ $3.52
Signal Strength: MEDIUM

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.

Opthea (ASX:OPT) current trading has maintained the Envelope Bands to overbought status and signalled the continuation of the long trading conditions. Currently, the Upper Band is 3.318.

Moving Average Envelopes are percentage-based envelopes set above and below a moving average. The moving average which forms the base for this indicator can be a simple or exponential moving average. Each envelope is then set the same percentage above or below the moving average. This creates parallel bands that follow price action. With a moving average as the base Moving Average Envelopes can be used as a trend following indicator.

Calculation: Moving Average Envelope:
1) Upper Envelope: 20-day SMA + (20-day SMA x .025);
2) Lower Envelope: 20-day SMA - (20-day SMA x .025);


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Moving Average Envelope

Company Close Change(%) Volume Value Signal
TRS Reject Shop 4.22 6.8 435,254 15.23 BULLISH
NSR National Storage 2.19 6.3 5,567,282 13.74 BULLISH
CVC CVC 2.19 4.3 344 9.09 BULLISH
RBL Rib Loc 1.05 4 628,044 14.18 BULLISH
SMN Structural Monitoring Systems 0.91 4 205,807 22.47 BULLISH
PGH Pact 2.8 3.3 1,537,551 50 BULLISH
SNZ Summerset Holdings 8.88 3 262 31.93 BULLISH
SOM Somnomed 2.84 2.9 5,088 56.28 BULLISH
MYS Mystate 5.31 2.9 82,539 15.15 BULLISH
FLT Flight Centre 42.2 2.9 444,374 29.22 BULLISH